Skip to main content

1 Result(s)

within Tina Jost Remove this filter Biomedicine, general Remove this filter

and

  1. Article

    Open Access

    PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts

    PARP inhibitors niraparib and talazoparib are FDA approved for special cases of breast cancer. PARP is an interesting repair protein which is frequently affected in cancer cells. We studied the combined action...

    Verena Weigert, Tina Jost, Markus Hecht, Ilka Knippertz, Lucie Heinzerling… in BMC Cancer (2020)

    Download PDF (2090 KB) View Article